| $—2025-01-01 | Pivotal Health | Steve Kraus |
| $60M2024-10-16 |  Oshi Health | Steve Kraus |
| $17M2024-05-30 |  Plenful | Andrew Hedin, Steve Kraus |
| $50M2024-05-14 | SmarterDx | Steve Kraus |
| $150M2024-02-23 |  Abridge | Sameer Dholakia, Steve Kraus |
| $30M2023-10-26 | Abridge | Sameer Dholakia, Steve Kraus |
| $9M2023-10-03 | Plenful | Andrew Hedin, Steve Kraus |
| $8M2023-09-19 | Mural Health | Andrew Hedin, Steve Kraus |
| $30M2023-04-10 | Oshi Health | Steve Kraus |
| $—2023-01-01 | Ansible Health | Steve Kraus |
| $30M2022-10-12 | Folx Health | Steve Kraus |
| $13M2022-08-11 | Abridge | Sameer Dholakia, Steve Kraus |
| $20M2022-05-10 | Turquoise | Julie Yoo, Steve Kraus |
| $25M2022-03-14 |  House Rx | First Round, Steve Kraus |
| $50M2022-02-28 |  Qventus | Andrew Hedin, Matthew Howard, Steve Kraus |
| $—2021-12-01 | US Health Partners | Steve Kraus |
| $23M2021-10-12 | Oshi Health | Steve Kraus |
| $5M2021-07-22 | Turquoise | Julie Yoo, Steve Kraus |
| $20M2021-05-25 | Clearing | Byron Deeter, Steve Kraus, Keith Rabois |
| $60M2021-05-05 |  Groups Recover Together | Steve Kraus |
| $25M2021-02-02 | Folx Health | Steve Kraus |
| $100M2021-01-25 |  TScan Therapeutics | Andrew Hedin, Steve Kraus |
| $23M2021-01-07 | Aspen RxHealth | Steve Kraus |
| $300M2021-01-05 | Hinge Health | Andrew Hedin, Elliott Robinson, Ben Blume, Steve Kraus |
| $4M2020-12-03 | Folx Health | Steve Kraus |
| $10M2020-10-06 | Abridge | Steve Kraus |
| $500M2020-09-22 | Neuehealth | Andrew Hedin, Steve Kraus |
| $50M2020-08-06 |  Ginger | Steve Kraus |
| $100M2020-03-12 | Kymera Therapeutics | Andrew Hedin, Steve Kraus |
| $90M2020-02-04 | Hinge Health | Andrew Hedin, Elliott Robinson, Ben Blume, Steve Kraus |
| $35M2020-01-10 | TScan Therapeutics | Andrew Hedin, Steve Kraus |
| $640M2019-12-17 | Neuehealth | Andrew Hedin, Steve Kraus |
| $—2019-07-24 | TScan Therapeutics | Andrew Hedin, Steve Kraus |
| $—2019-03-30 | Verata Health (Now Part of Olive) | Steve Kraus |
| $25M2019-03-14 |  Artemis Health | Andrew Hedin, Steve Kraus |
| $200M2018-11-29 | Neuehealth | Andrew Hedin, Steve Kraus |
| $65M2018-11-13 | Kymera Therapeutics | Andrew Hedin, Steve Kraus |
| $4M2018-06-01 |  Subtle Medical | Andrew Hedin, Steve Kraus, Scott Barclay, James Hardiman |
| $30M2018-05-14 | Qventus | Andrew Hedin, Steve Kraus, Matthew Howard |
| $75M2018-04-04 |  Welltok | Steve Kraus |
| $48M2017-11-14 |  Collective Medical Technologies | Andrew Hedin, Steve Kraus, Jeremy Levine |
| $—2017-11-02 | Allena Pharmaceuticals | Steve Kraus |
| $73M2017-10-12 | Welltok | Steve Kraus |
| $160M2017-06-01 | Neuehealth | Andrew Hedin, Steve Kraus |
| $—2017-01-01 | Recover Together | Andrew Hedin, Steve Kraus |
| $34M2016-10-05 | Welltok | Steve Kraus |
| $15M2016-07-13 | Docent Health | Steve Kraus |
| $49M2016-06-14 | Alcresta | Steve Kraus |
| $80M2016-04-05 | Bright Healthcare | Steve Kraus |
| $2M2016-01-11 | Docent Health | Steve Kraus |
| $37M2015-01-08 | Welltok | Steve Kraus |
| $25M2014-12-04 | Allena Pharmaceuticals | Steve Kraus |
| $40M2014-09-08 | Flex Pharma | Steve Kraus |
| $10M2013-07-22 | Alcresta | Steve Kraus |
| $12M2013-05-02 | DocuTap | Steve Kraus |
| $1M2012-08-03 | Lumere | Steve Kraus |
| $18M2012-04-24 | Liazon | Steve Kraus |
| $10M2012-04-17 | Alcresta | Steve Kraus |
| $15M2011-11-16 | Allena Pharmaceuticals | Steve Kraus |
| $20M2011-11-11 | Verastem Oncology | Steve Kraus |
| $6M2011-10-11 | OvaScience | Steve Kraus |
| $32M2011-07-14 | Verastem Oncology | Steve Kraus |
| $16M2010-11-16 | Verastem Oncology | Steve Kraus |
| $35M2008-04-02 | Transave | Steve Kraus |
| $31M2007-10-01 |  Acceleron Pharma, Inc | Steve Kraus |
| $—2007-01-01 | Insmed | Steve Kraus |
| $37M2006-04-19 | Sirtris Pharmaceuticals | Steve Kraus |
